Methylation based CTDNA serial monitoring correlates with immunotherapy response in non-small cell lung cancer
Year: 2024
Type: article
Abstract: Purpose: Circulating tumor DNA (ctDNA) can reflect the genetic and epigenetic composition of malignancies and can serve as a non-invasive biomarker for cancer diagnostics and monitoring. This study aimed to evaluate the utility of a methylation-based ctDNA assay as a predictive tool in non-small cell lung cancer (NSCLC) anti-PD1 based immunotherapy monitoring.
Source: The Journal of Liquid Biopsy
Authors: Angela Hsiao, Brian Woodward, Patrick Ye, Matthew Varga, Ghaith Altaie, Kevin Lu, Sydne Langpap, Zeqian Li, Gary Palmer, Hatim Husain
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,080
OpenAlex ID: W4404580967